Kim, Y.M., Jeong, S.-H., Kim, J.-W., Lee, S.H., Hwang, J.H., Park, Y.S., Kim, N., Lee, J.S., Kim, H.Y. and Lee, D.H. (2011) Chronic Hepatitis B, Non-Hodgkin’s Lymphoma, and Effect of Prophylactic Antiviral Therapy. Journal of Clinical Virology, 51, 237-241.

has been cited by the following article:

• TITLE: Hepatitis B Virus Infection in B-Cell Non-Hodgkin’s Lymphoma, and Effect of Entecavir in Prophylactic Antiviral Therapy

  AUTHORS: Jinjing Chen, Haizhen Yi, Hong Cen, Wei Yan

  KEYWORDS: Hepatitis B infection, B-NHL, Prevalence, Prophylactic Antiviral Therapy

  JOURNAL NAME: Health, Vol.8 No.5, March 30, 2016

  ABSTRACT: Background: specialized studies on hepatitis B virus (HBV) infection and B-NHL (B-cell Non-Hodgkin’s Lymphoma) are limited, as well as prophylactic antiviral therapy for B-NHL patients with HBV infection who are receiving anticancer chemotherapy. This study aims to investigate the association between HBV infection and B-NHL, and to evaluate the effect of prophylactic antiviral therapy for HBV-infected B-NHL patients. Study design: A retrospective, case-control study was performed. The study group included 420 patients with B-NHL who were consecutively diagnosed from May 2003 to October 2013 (age range, 14 - 71 years), and the control group included 1280 Chinese residents in Guangxi who participated in the Health Survey (age range, 18 - 74 years). We compared the prevalence rate of HBV infection and clinic-pathologic characteristics between the two groups. The prevalence rate of HBV infection in our study was 34.7% (146/420), higher than the prevalence rate of 13.9% (178/1280) in the general population (P